Andrew is a corporate lawyer with extensive experience across a range of domestic and cross-border matters, in particular private equity and venture capital transactions, foreign investment and private treaty M&A.
He advises financial sponsors and major corporates on domestic and cross-border acquisitions and disposals, as well as advising on management incentive plans and general corporate matters for private equity portfolio companies.
He has a particular focus on technology and software transactions, and regularly advises US- and UK-based clients on acquisitions and investments in Australian businesses in the tech space, helping them navigate the differences in market practice between jurisdictions and advising on Australia’s foreign investment laws.
Andrew brings significant international expertise, having practiced at a leading London City firm and spent time on secondment at a London-based private equity fund, where he advised on the divestment of businesses based in the United States, Brazil and Italy, as well as general corporate and funds management matters.
Acting on its Series A (2020) and Series B (2022) investments in solar tech business, 5B.
Acting on their Series A investment in Zepto, a real-time account-to-account merchant payments platform (2022).
Acting in relation to the acquisition by portfolio company, Aplos, of non-profit fundraising platform, Raisely (2023).
Acting in relation to its divestment of V8 Supercars to RACE (2021), its partial divestment of illion (formerly Dunn & Bradstreet) to Macquarie (2020) and its divestment of LCR Group to Qube Holdings (2019).
Acting on seed investments in BioScout and Hillridge Technologies (2022).
Acting on its partial sale to The Growth Fund (2021).
Acting in relation to its acquisitions of Sphere Surgical (2019), PumpnSeal (2020), FITT Resources (2021) and Anti Corrosion Technology (2022).
Acting on its acquisition of NextGen Group (2024).
Advising the shareholders of Fyfe Pty Ltd on its sale to Mercury Capital (2024).
Acting on its Series A investment in Sicona Battery Technologies (2023).
Acting for Lacima, which provides technology solutions for trading and risk management in energy and commodities markets trading businesses, on its sale to the European Energy Exchange (EEX), which is part of the Deutsche Börse (2022).
Acting in relation to its acquisition of eftSure, a SaaS anti-fraud payment protection technology business (2021).
Acting in relation to its divestment of Biomedx (2023), its investment in Baby Village (2021), its acquisitions of Simplyai (2023) and of Melbourne IT Consulting (Seisma) (2020), and the portfolio acquisitions by Seisma of coIB (2020), Smart Apps (2021), Braestone (2021) and Data Addiction (2023), and the portfolio acquisition by Genea Fertility of Fertility SA (2023).
Acting for Payrix Inc (an investee company of Blue Star Innovation Partners and Providence Strategic Growth, the growth equity affiliate of Providence Equity Partners) on its acquisition of IntegraPay, a payments service provider (2020).
Advising on their $105m investment in construction safety software business, HammerTech (2024).
Acting for Actionstep, a cloud-based legal practice management platform, and portfolio company of Serent Capital, on its acquisition of legal software businesses, LawMaster (2022) and FilePro (2023).
Acting for Amazon aggregator (and investee company of Silver Lake, Advent International and Oaktree) Thrasio in relation to a series of acquisitions in Australia (2021).
Acting for portfolio company, MoxiWorks on its acquisition of ActivePipe, a real estate tech offering providing email and marketing automation solutions (2022).